ODAIA is looking forward to taking part in the upcoming Ontario Pharmaceutical Marketing Association July event: "How Canadian Marketers Can Use AI-Powered Innovations to Boost Their Brands".
The virtual session will explore how Canadian marketers can use AI-powered innovations to boost their brands. The panel discussion will be moderated by Jennifer Meldrum, Co-Founder & Managing Partner, PEAK Pharma Solutions Inc.
Speakers on this panel will include Orchid Jahanshahi, Vice President of Lifescience at ODAIA and Don Watts, President at Khure Health and Shawna Boynton, Omnichannel Marketing Manager at Novo Nordisk. An invitation for the registration can be found here.
Orchid Jahanshahi, VP of Life Sciences at ODAIA
A persuasive and passionate commercial leader with extensive experience in Marketing Management, Sales Management and Global Brand Strategy in the biopharmaceutical sector. In her current role as VP Commercial, Life Sciences at ODAIA, Orchid is responsible for the Sales and Marketing strategy of MAPTUAL.
Don Watts, President at Khure Health
Healthcare, medical device, pharmaceutical industry business leader with an extensive track record in growing businesses and teams. Along with a sincere passion for making a positive difference in patients’ lives and building long-term, trusted relationships with colleagues and key customers.
Shawna Boynton, Omni-channel Marketing Manager at Novo Nordisk
Shawna has eight years of experience in the Pharmaceutical industry. She has recently joined Novo Nordisk Canada to lead the Digital Transformation and has a customer experience focus to bring value to customers and optimal health outcomes to patients while driving profitable growth.
MAPTUAL is a pharma's first AI-powered Customer Data Platform (CDP) that unifies pharma data from across internal and external sources to deliver real-time insights to customer-facing teams, so they can create hyper-personalized customer engagements.
The global pandemic has changed the customer-facing pharma business, forever. With direct access more difficult than ever, and HCP preferences shifting permanently toward digital engagement and personalized support, digital transformation is now a main priority.
ODAIA’s Trend Report highlights the key trends facing Pharma today to embrace AI.
A digital tool that makes next best action recommendations, identifies HCP receptiveness and targets effective omni-channel actions in order to achieve desired objectives.Visit MAPTUAL